However, in a recent randomized, placebo-controlled trial on 160 breast cancer patients treated with aromatase inhibitors (the VITAL study) vitamin D supplementation was not associated with any clear beneficial effects on musculoskeletal symptoms [67]. The gene discussed is CYP19A1; the disease is breast carcinoma.